RoslinCT offers a range of integrated services from technology transfer, process and assay development through to GMP manufacturing, QP certification and batch release of cell-based therapies for clinical trials. RoslinCT engages with leading cell and gene therapy developers providing a personalised service to accelerate the path to market.


RoslinCT uniquely combines the trusted resources in cell isolation, manufacture and characterisation, a mature quality management system and fully licenced GMP manufacturing facilities together with a passion for innovation and a flexible and personalised approach to support clients at every step of the cell therapy development journey.

Based at the Edinburgh BioQuarter, RoslinCT operates a fully licensed GMP manufacturing facility and has a proven track record in the delivery of cell based products for clinical trials. A comprehensive range of CDMO services is offered, ranging from:

  • Gap analysis
  • Tissue procurement
  • Process optimisation and scale-up
  • GMP manufacture
  • Cell banking
  • In-process and final product QC testing
  • QP batch certification
  • GMP storage
  • Controlled temperature distribution to clinical sites worldwide.

As an organisation we leverage our cell therapy - focused expertise and strong links established across the UK’s regenerative medicine supply chain to de-risk client product development and support our clients in fulfilling their objective of providing compliant, sustainable and affordable therapies.

With a highly experienced and professional team, we are committed to developing longstanding relationships with our clients and supporting them across all stages of Cell Therapy development while applying the highest standards of quality and service across all aspects of our business.


Nine Edinburgh bioQuarter
9 Little France Road
EH16 4UX